TD Cowen Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $288
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $256 to $290
Cencora's Strong US Healthcare Performance and Strategic Acquisition Drive Buy Rating
Barclays Adjusts Cencora Price Target to $290 From $263, Maintains Overweight Rating
Cencora Is Maintained at Outperform by Evercore ISI Group
Cencora Analyst Ratings
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $249 to $292
Mizuho Securities Sticks to Its Hold Rating for Cencora (COR)
Leerink Partners Adjusts Cencora Price Target to $287 From $275
Morgan Stanley Maintains Cencora(COR.US) With Hold Rating, Maintains Target Price $242
Morgan Stanley Keeps Their Hold Rating on Cencora (COR)
TD Cowen Adjusts Cencora Price Target to $263 From $271
Cencora Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Cencora(COR.US) With Buy Rating, Cuts Target Price to $250
Cencora Analyst Ratings
Leerink Partners Maintains Outperform on Cencora, Lowers Price Target to $275
Citi Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $284
Cencora Cut to Neutral From Buy by B of A Securities
Cencora Analyst Ratings
BofA Securities Downgrades Cencora(COR.US) to Hold Rating, Cuts Target Price to $245